[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100405367":3},{"organization":4,"armGroups":7,"interventions":25,"overallOfficials":38,"centralContacts":42,"locations":53,"responsibleParty":99,"collaborators":101,"id":108,"slug":47,"hasResults":109,"nctId":110,"briefTitle":111,"officialTitle":112,"acronym":113,"eligibilityCriteria":114,"healthyVolunteers":115,"sex":116,"minAge":117,"maxAge":47,"enrollmentInfo":118,"targetDuration":47,"studyType":121,"phases":122,"briefSummary":124,"conditions":125,"keywords":47,"overallStatus":56,"whyStopped":47,"lastUpdateSubmitDate":130,"lastUpdatePostDateStruct":131,"startDateStruct":134,"completionDateStruct":136,"leadSponsor":138,"locationsCount":139},{"fullName":5,"class":6},"Assistance Publique - Hôpitaux de Paris","OTHER",[8,13,17,21],{"label":9,"type":6,"description":10,"interventionNames":11},"Group 1","Patients with confirmed infection by SARS-Cov-2, requiring a hospitalization in intensive care unit",[12],"Diagnostic Test: carotid-femoral pulse-wave velocity",{"label":14,"type":6,"description":15,"interventionNames":16},"Group 2","Patients with confirmed infection by SARS-Cov-2, requiring a hospitalization in a medicine unit",[12],{"label":18,"type":6,"description":19,"interventionNames":20},"Group 3","Patients with confirmed infection by SARS-Cov-2, not requiring hospitalization",[12],{"label":22,"type":6,"description":23,"interventionNames":24},"Group 4","4\\) individuals having performed a test for SARS-Cov-2 infection, but resulted to be negative",[12],[26],{"type":27,"name":28,"description":29,"armGroupLabels":30,"otherNames":31},"DIAGNOSTIC_TEST","carotid-femoral pulse-wave velocity","early vascular aging tests",[9,14,18,22],[32,33,34,35,36,37],"arterial distensibility","wave separation\u002Fintensity analysis","flow-mediated dilation","cardiac diastolic dysfunction","myocardial stiffness","central blood pressure",[39],{"name":40,"affiliation":5,"role":41},"Pierre BOUTOUYRIE, MD PHD","PRINCIPAL_INVESTIGATOR",[43,49],{"name":44,"role":45,"phone":46,"phoneExt":47,"email":48},"Rosa Maria BRUNO, MD","CONTACT","+33 1 53 98 79 67",null,"rosa-maria.bruno@inserm.fr",{"name":50,"role":45,"phone":51,"phoneExt":47,"email":52},"Laura LE MAO, MSc","+33 1 56 09 54 97","laura.le-mao@aphp.fr",[54,71,85],{"facility":55,"status":56,"city":57,"state":47,"zip":58,"country":59,"cosmosGeoPoint":60,"geoPoint":65,"contacts":66},"CHRU Nancy","RECRUITING","Nancy","54500","France",{"type":61,"coordinates":62},"Point",[63,64],6.18496,48.68439,{"lat":64,"lon":63},[67],{"name":68,"role":45,"phone":69,"phoneExt":47,"email":70},"Athanase BENETOS, PhD","+ 33 3 83 15 33 22","a.benetos@chru-nancy.fr",{"facility":72,"status":56,"city":73,"state":47,"zip":74,"country":59,"cosmosGeoPoint":75,"geoPoint":79,"contacts":80},"Hôpital Européen Georges Pompidou - APHP","Paris","75015",{"type":61,"coordinates":76},[77,78],2.3488,48.85341,{"lat":78,"lon":77},[81],{"name":82,"role":45,"phone":83,"phoneExt":47,"email":84},"Pierre BOUTOUYRIE, PUPH","+33 1 56 09 39 91","Pierre.boutouyrie@aphp.fr",{"facility":86,"status":56,"city":87,"state":47,"zip":88,"country":59,"cosmosGeoPoint":89,"geoPoint":93,"contacts":94},"CHU Rouen","Rouen","76031",{"type":61,"coordinates":90},[91,92],1.09932,49.44313,{"lat":92,"lon":91},[95],{"name":96,"role":45,"phone":97,"phoneExt":47,"email":98},"Jérémy BELLIEN, PUPH","+33 2 32 88 14 28","jeremy.bellien@chu.rouen.fr",{"type":100,"investigatorFullName":47,"investigatorTitle":47,"investigatorAffiliation":47,"oldNameTitle":47,"oldOrganization":47},"SPONSOR",[102,105],{"name":103,"class":104},"The Association for Research into Arterial Structure and Physiology","UNKNOWN",{"name":106,"class":107},"Institut National de la Santé Et de la Recherche Médicale, France","OTHER_GOV","100405367",false,"NCT04558450","Covid-19 Effects on Arterial Stiffness and Vascular Aging (CARTESIAN)","Covid-19 Effects on ARTErial StIffness and Vascular AgiNg","CARTESIAN","Inclusion Criteria:\n\n* age \\>18 years, both sexes;\n* written informed consent;\n* affiliation to a social security regime;\n* a recent diagnosis of COVID19 (6±3 months) proven by PCR or serology (for group 1,2,3)\n* hospitalization in intensive care unit for COVID19 (for group 1)\n* hospitalization in a medicine unit for COVID19 (for group 2)\n* no hospitalization for COVID19 or hospitalization less than 24h (for group 3)\n* a negative test for SARS-nCOV2 infection (PCR or serology)(for group 4)\n\nExclusion Criteria:\n\n* Age \\\u003C18 years\n* Inability to express consent of the study\n* Diseases carrying out a life -expectancy \\\u003C1 year according to clinical judgment\n* Pregnancy and breastfeeding\n* Foreseen inability to attend scheduled visits",true,"ALL","18 Years",{"count":119,"type":120},360,"ESTIMATED","INTERVENTIONAL",[123],"NA","The purpose of the study is to evaluate the presence of early vascular aging 6 months and 12 months after COVID-19 infection.",[126,127,128,129],"Covid19","Arterial Stiffness","Endothelial Dysfunction","Diastolic Dysfunction","2021-11-15",{"date":132,"type":133},"2021-11-22","ACTUAL",{"date":135,"type":133},"2020-09-21",{"date":137,"type":120},"2033-03",{"name":5,"class":6},3]